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A B S T R A C T
Purpose: Focal cortical dysplasia (FCD) represents a common cause of refractory epilepsy. It is considered
a sporadic disorder, but its occasional familial occurrence suggests the involvement of genetic
mechanisms.
Methods: Siblings with intractable epilepsy were referred for epilepsy surgery evaluation. Both patients
were examined using video-EEG monitoring, MRI examination and PET imaging. They underwent left
anteromedial temporal lobe resection.
Results: Electroclinical features pointed to left temporal lobe epilepsy and MRI examination revealed
typical signs of left-sided hippocampal sclerosis and increased white matter signal intensity in the left
temporal pole. PET examination conﬁrmed interictal hypometabolism in the left temporal lobe.
Histopathological examination of resected tissue demonstrated the presence FCD type IIIa, i.e.
hippocampal sclerosis and focal cortical dysplasia in the left temporal pole.
Conclusion: We present a unique case of refractory mesial temporal lobe epilepsy in siblings,
characterized by an identical clinical proﬁle and histopathology of FCD type IIIa, who were successfully
treated by epilepsy surgery. The presence of such a high concordance between the clinical and
morphological data, together with the occurrence of epilepsy and febrile seizures in three generations of
the family pedigree points towards a possible genetic nature of the observed FCD type IIIa.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Focal cortical dysplasia (FCD) is characterized by disorganiza-
tion and structural abnormalities of the cerebral cortex due to
alterations in cell proliferation, differentiation and migration
during cortical development [1]. The presence of FCD is associated
with a high risk of intractable epilepsy in both children and adults.
It was ﬁrst described in detail by Taylor and colleagues in patients
who underwent temporal lobectomy [2]. FCD located in the
temporal lobe has been reported to be a common dual pathology in
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the introduction of type IIIa FCD in the latest revision of the FCD
classiﬁcations [4]. However, the causal relationship between FCD
and HS remains unknown, as well as the etiopathogenesis and
genetics of the FCDs. Neither identical FCD, nor FCD in combination
with HS have been previously reported in related individuals. We
herein describe an unusual and unique case of mesial temporal
lobe epilepsy (MTLE) in siblings characterized by a nearly identical
clinical course and histopathological ﬁndings of FCD Type IIIa.
2. Case reports
2.1. Case 1
A twenty-seven year old woman with a brother, grandmother
and two cousins diagnosed with epilepsy (supplemental Fig. 1A).
Her mother experienced febrile seizures (FS) in early childhood
and has a normal brain MRI. Whether FS were simple or complex
could not be determined from her personal history. The exactserved.
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cousins is also not known.
The patient is from an uncomplicated pregnancy. Following her
birth she developed pneumonia, which was treated with
antibiotics. At 12 months of age, she developed complicated FS.
At nine years of age, she experienced her ﬁrst unprovoked seizure.
From the onset, her seizures were refractory to medical treatment
and were classiﬁed as complex partial. The seizures started with
initial aura followed by early oral automatisms, right face clonic
seizure, asymmetric tonic limb posturing (ﬁgure of four sign) and
occasional secondary generalization. Due to intractability, the
patient underwent presurgical evaluation. Video-EEG monitoring
conﬁrmed the seizure semiology described above. In scalp EEG,
seizure onset was characterized by initial attenuation of back-
ground activity followed by rhythmic 5–6 Hz activity in the left
sphenoidal (Sp1) and fronto-temporal (T3, F9) electrodes (supple-
mental Fig. 1C). Interictally, spikes and intermittent slow waves in
the left anterior temporal region and left sphenoidal electrode
were present (supplemental Fig. 1B). The MRI revealed typical
signs of left-sided HS. Increased signal intensity in T2-weighted
images and blurring of the grey-white matter junction were
present in the white matter of the left temporal pole (Fig. 1A–C).Fig. 1. MRI ﬁndings in siblings. (A, B) The sister’s MRI was characterized by the presence 
images (FLAIR) in the left hippocampus (B). (C) Increased signal intensity in T2-weighte
changes in the left hippocampus and also in the left temporal pole (F) (Department o
conﬁrmed by histopathological examination.FDG-PET showed left temporal lobe hypometabolism. The patient
underwent left anteromedial temporal lobe resection at the age of
22 years. Histopathological examination demonstrated the pres-
ence of FCD type Ib in the left temporal pole and adjacent
parahippocampal gyrus and HS, classiﬁed as FCD type IIIa
(supplementary Fig. 2A–C). Following surgery, she became seizure
free with persisting auras only (Engel 1B). One year following
the surgery, she developed psychogenic non-epileptic seizures.
The patient refused to be genetically tested for presence of Scn1a
mutation.
2.2. Case 2
A brother of the women described in case 1, twenty-nine year
old male from a pharmacologically supported pregnancy compli-
cated by abnormal fetal position and clouded amniotic ﬂuid. At
14 months of age, following a mild head trauma, a seizure with loss
of consciousness and right-sided hemiclonus occurred. At
16 months of age, he experienced a complicated FS, which was
followed by the development of spontaneous and recurrent
seizures. Until the age of eight years, the seizures were fully
controlled by antiepileptic drugs then medication was withdrawn.of atrophy in T1-weighted images (A) and increased signal intensity in T2-weighted
d images (FLAIR) in the left temporal pole. (D–F) The brother’s MRI showed similar
f Radiological Techniques, Motol University Hospital, Prague). MRI ﬁndings were
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characterized by epigastric aura followed by oral automatisms,
right face clonic seizure, right head version and asymmetric tonic
seizure. Occasionally, he suffered from secondarily generalized
tonic-clonic seizures. Ictal EEG was characterized by initial
attenuation followed by rhythmic 5–6 Hz activity in the left
sphenoidal electrode (Sp1) and fronto-temporal region (F7, T3;
supplemental Fig. 1E). Interictal EEG demonstrated spikes and
intermittent slow wave activity in the same region (supplemental
Fig. 1 D). The MRI revealed a similar pathology to his sister
(Fig. 1D–F) and left temporal lobe hypometabolism was identiﬁed
by FDG-PET. The patient underwent anteromedial temporal lobe
resection at the age of 25 years. FCD type IIIa was diagnosed by
histopathological characterization (supplemental Fig. 2D–F). After
the surgery, he became seizure free (Engel 1A). Genetic Scn1a
testing was done through DNA sequencing and multiplex ligation-
dependent probe ampliﬁcation. None of the tests demonstrated
any abnormality in the Scn1a gene.
3. Discussion
FCDs belong to a group of disorders known as malformations of
cortical development. It is estimated that up to 40% of medically
refractory epilepsy is caused by malformations of cortical
development including FCDs [5]. Although FCDs represent a
frequent cause of epilepsy, the pathological and etiological factors
are poorly understood. It has been demonstrated that speciﬁc
types of cortical malformations have a genetic origin due to
mutations in genes controlling cell proliferation, neuronal migra-
tion and apoptosis [6]. The genetic cause of FCD could be explained
by the occurrence of de novo gene mutation and/or a non-inherited
multifactorial mechanism. A recently published study of familial
cases of FCDs showed that the clinical proﬁle, location, spatial
extent and type of FCD often varied between affected family
members pointing to the possibility of the double hit theory being
responsible for such variations [7]. This theory assumes that the
genetic polymorphism provides a susceptible background for
environmental factors to alter pre- and postnatal cortical
development. Morphological heterogeneity of FCDs can be
explained by the existence of multiple pathogenic mechanisms
and molecular pathways. For example, enhanced mTOR signalling
has been shown to be a pathogenetic mechanism involved in FCD
type IIb, tuberous sclerosis and hemimegaencephaly.
FCD type IIIa identiﬁed in the cases presented is characterized by
the presence of cortical lamination abnormalities in the temporal
lobe associated with HS. This type of FCD is often found in patients
with refractory MTLE. It is well established that the presence of
dysplastic tissue in the temporal neocortex plays a crucial role in
mesial temporal lobe epileptogenesis, where even tissue with mild
dysplastic features can possess a strong epileptogenic potential,
sufﬁcient to induce MTLE [8]. The causal relationship between FCD,
HS and FS in the pathogenesis of MTLE has not yet been determined
and several alternative theories have been proposed. Complicated
FS are referred as one of the most frequent insults preceding the
development of HS, but some studies have also reported
complicated FS as a consequence of the pre-existing structural
lesion of the hippocampus or temporal lobe neocortex [9]. Some
authors proposed that early, frequent and intractable seizures
originating from the hippocampus could interfere with the
development of the neocortical temporal lobe [10] and thus lead
to the development of FCD. The underlying pathology, such as, HS
and/or cortical dysplasia, can generate seizures or lead to an
increased susceptibility to FS that could augment already present
structural lesions or play a crucial role in epileptogenesis. In our
previous study, patients with FCD type IIIa were characterized by a
more frequent absence of any initial precipitating insult in earlychildhood, when compared to patients with isolated HS. On the
contrary, meningitis was much more frequently present in the
history of patients with isolated HS and was not reported in patients
with FCD type IIIa [3]. Familial MTLE with or without HS and FS was
identiﬁed in several studies often with autosomal dominant
inheritance, but with incomplete penetrance, suggesting an
underlying genetic defect and involvement of genetic mechanisms
in the development of hippocampal damage. MTLE has been
described in several families with generalized epilepsy with FS plus
(GEFS+) syndrome due to Scn1b gene mutations [11]. Recent
genome-wide association study in large cohort of patients with
MTLE has revealed that variations in and near Scn1a gene can
increase the susceptibility to MTLE with HS and FS [12]. However,
none of the published familial cases described the simultaneous
presence of FCD and HS (FCD type IIIa). The co-occurrence of Scn1a
gene mutations with malformations of cortical development
(including FCD) was described in a small group of patients with
Dravet syndrome spectrum [13]. Studies in Scn1b-null mice
demonstrated that this gene product, voltage-gated sodium
channel b1 subunit, plays a critical role in postnatal brain
development [14]. Absence of any Scn1a mutation in the brother
makes the possibility of its involvement in the pathogenesis of
FCD type III highly unlikely. However, the pathogenesis may
involve different genes. For example, loss of Scn1b function results
in altered proliferation, migration and pathﬁnding of cells within
the postnatally developing hippocampus and cerebellum, repre-
senting the morphological substrate of increased hippocampal
excitability. The causal relationships between FCD, HS and FS in
the pathogenesis of MTLE remains to be determined. A growing
body of evidence and the results from the presented cases suggest
that genetic mechanisms should be always considered when the
pathogenesis of focal cortical dysplasia type IIIa is discussed.
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